Martina Mirlacher

6.8k total citations · 1 hit paper
62 papers, 5.3k citations indexed

About

Martina Mirlacher is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Martina Mirlacher has authored 62 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Oncology, 32 papers in Molecular Biology and 17 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Martina Mirlacher's work include HER2/EGFR in Cancer Research (26 papers), Monoclonal and Polyclonal Antibodies Research (16 papers) and Gene expression and cancer classification (11 papers). Martina Mirlacher is often cited by papers focused on HER2/EGFR in Cancer Research (26 papers), Monoclonal and Polyclonal Antibodies Research (16 papers) and Gene expression and cancer classification (11 papers). Martina Mirlacher collaborates with scholars based in Switzerland, Germany and United States. Martina Mirlacher's co-authors include Guido Sauter, Ronald Simon, Alessandro Lugli, Marcel Bundi, Stephan Dirnhofer, Philip Went, Peter Schraml, Michael J. Mihatsch, Sandra Meier and Hanspeter Spichtin and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Martina Mirlacher

61 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Frequent EpCam protein expression in human carcinomas

2004 671 citations Philip Went, Alessandro Lugli et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Martina Mirlacher Switzerland	39	2.5k	2.2k	1.6k	1.1k	816	62	5.3k
Jianming Ying China	43	2.6k 1.0×	2.7k 1.2×	2.1k 1.3×	1.3k 1.1×	524 0.6×	283	6.1k
Marija Drobnjak United States	31	3.3k 1.3×	3.9k 1.8×	2.0k 1.3×	1.3k 1.2×	441 0.5×	41	7.0k
Priti Lal United States	34	3.0k 1.2×	2.5k 1.2×	2.4k 1.5×	2.0k 1.8×	538 0.7×	128	6.7k
Víctor Moreno Spain	35	3.8k 1.5×	1.8k 0.8×	1.2k 0.8×	624 0.6×	664 0.8×	287	5.5k
Katja Specht Germany	36	1.9k 0.8×	2.5k 1.1×	1.2k 0.8×	751 0.7×	352 0.4×	85	5.0k
Frederik Marmé Germany	36	4.3k 1.7×	2.1k 0.9×	1.1k 0.7×	2.7k 2.4×	840 1.0×	236	6.6k
Maarit Bärlund Finland	16	2.2k 0.9×	3.1k 1.4×	724 0.5×	985 0.9×	636 0.8×	27	5.0k
Yoon‐La Choi South Korea	35	1.6k 0.6×	1.4k 0.7×	930 0.6×	1.1k 1.0×	426 0.5×	125	3.7k
Andrea T. Hooper United States	32	2.6k 1.1×	2.8k 1.3×	645 0.4×	1.2k 1.0×	475 0.6×	56	5.8k
Laurence Desjardins France	39	1.7k 0.7×	1.3k 0.6×	869 0.6×	454 0.4×	898 1.1×	188	5.0k

Countries citing papers authored by Martina Mirlacher

Since Specialization

Citations

This map shows the geographic impact of Martina Mirlacher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martina Mirlacher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martina Mirlacher more than expected).

Fields of papers citing papers by Martina Mirlacher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martina Mirlacher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martina Mirlacher. The network helps show where Martina Mirlacher may publish in the future.

Co-authorship network of co-authors of Martina Mirlacher

This figure shows the co-authorship network connecting the top 25 collaborators of Martina Mirlacher. A scholar is included among the top collaborators of Martina Mirlacher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martina Mirlacher. Martina Mirlacher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Press, Michael F., Guido Sauter, Marc Buyse, et al.. (2016). HER2 gene amplification testing by fluorescence in situ hybridization (FISH): Comparison of the ASCO-CAP guidelines with FISH scores used for enrollment in breast cancer international research group (BCIRG) clinical trials.. Journal of Clinical Oncology. 34(15_suppl). 515–515. 1 indexed citations

Minner, Sarah, Eike Burandt, Jens Köllermann, et al.. (2010). Low Level Her2 Overexpression Is Associated with Rapid Tumor Cell Proliferation and Poor Prognosis in Prostate Cancer. Clinical Cancer Research. 16(5). 1553–1560. 110 indexed citations

Simon, Ronald, Martina Mirlacher, & Guido Sauter. (2010). Immunohistochemical Analysis of Tissue Microarrays. Methods in molecular biology. 664. 113–126. 56 indexed citations

Zustin, Jozef, Maria Tsourlakis, Eike Burandt, et al.. (2009). HER-2/neu analysis in breast cancer bone metastases. Journal of Clinical Pathology. 62(6). 542–546. 12 indexed citations

Fleischmann, Achim, Thorsten Schlomm, Hartwig Huland, et al.. (2008). Distinct Subcellular Expression Patterns of Neutral Endopeptidase (CD10) in Prostate Cancer Predict Diverging Clinical Courses in Surgically Treated Patients. Clinical Cancer Research. 14(23). 7838–7842. 51 indexed citations

Tapia, Coya, Katharina Glatz, Hedvika Novotny, et al.. (2007). Close association between HER-2 amplification and overexpression in human tumors of non-breast origin. Modern Pathology. 20(2). 192–198. 54 indexed citations

Oeggerli, Martin, Peter Schraml, Christian Ruiz, et al.. (2006). E2F3 is the main target gene of the 6p22 amplicon with high specificity for human bladder cancer. Oncogene. 25(49). 6538–6543. 40 indexed citations

Al‐Kuraya, Khawla S., Peter Schraml, Salwa Sheikh, et al.. (2005). Predominance of high-grade pathway in breast cancer development of Middle East women. Modern Pathology. 18(7). 891–897. 57 indexed citations

Press, Michael F., Guido Sauter, Leslie Bernstein, et al.. (2005). Diagnostic Evaluation of HER-2 as a Molecular Target: An Assessment of Accuracy and Reproducibility of Laboratory Testing in Large, Prospective, Randomized Clinical Trials. Clinical Cancer Research. 11(18). 6598–6607. 232 indexed citations

10.

Lugli, Alessandro, Hanspeter Spichtin, Robert Maurer, et al.. (2005). EphB2 Expression across 138 Human Tumor Types in a Tissue Microarray: High Levels of Expression in Gastrointestinal Cancers. Clinical Cancer Research. 11(18). 6450–6458. 83 indexed citations

11.

Went, Philip, Stephan Dirnhofer, Marcel Bundi, et al.. (2004). Prevalence of KIT Expression in Human Tumors. Journal of Clinical Oncology. 22(22). 4514–4522. 174 indexed citations

12.

Simon, Ronald, Martina Mirlacher, Robert Maurer, et al.. (2004). TRIO Amplification and Abundant mRNA Expression Is Associated with Invasive Tumor Growth and Rapid Tumor Cell Proliferation in Urinary Bladder Cancer. American Journal Of Pathology. 165(1). 63–69. 56 indexed citations

13.

Kaimaktchiev, Vassil, Luigi Terracciano, Luigi Tornillo, et al.. (2004). The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas. Modern Pathology. 17(11). 1392–1399. 170 indexed citations

14.

Al‐Kuraya, Khawla S., Peter Schraml, J. Torhorst, et al.. (2004). Prognostic Relevance of Gene Amplifications and Coamplifications in Breast Cancer. Cancer Research. 64(23). 8534–8540. 279 indexed citations

15.

Mirlacher, Martina, Marlis Kasper, Martina Storz, et al.. (2004). Influence of slide aging on results of translational research studies using immunohistochemistry. Modern Pathology. 17(11). 1414–1420. 77 indexed citations

16.

Simon, Ronald, Martina Mirlacher, & Guido Sauter. (2004). Tissue Microarrays. Humana Press eBooks. 97. 377–390. 12 indexed citations

17.

Zellweger, Tobias, Martina Mirlacher, Andrew G. Glass, et al.. (2003). Tissue microarray analysis reveals prognostic significance of syndecan‐1 expression in prostate cancer. The Prostate. 55(1). 20–29. 107 indexed citations

18.

Pache, Mona, Katharina Glatz, Stephan Dirnhofer, et al.. (2003). Sequence analysis and high-throughput immunhistochemical profiling of KIT (CD 117) expression in uveal melanoma using tissue microarrays. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 443(6). 741–744. 45 indexed citations

19.

Simon, Ronald, Martina Mirlacher, & Guido Sauter. (2003). Tissue microarrays in cancer diagnosis. Expert Review of Molecular Diagnostics. 3(4). 421–430. 48 indexed citations

20.

Moch, Holger, Peter Schraml, Lukas Bubendorf, et al.. (1999). High-Throughput Tissue Microarray Analysis to Evaluate Genes Uncovered by cDNA Microarray Screening in Renal Cell Carcinoma. American Journal Of Pathology. 154(4). 981–986. 309 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact